Skip to content

Frontlight ResearchEarly access

Trial site

COI Centro Oncologico Internacional S.A.P.I. de C.V. (Site 2902)

Coyoacán, Mexico City 04700, MexicoNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Endometrial cancer

Running trials

Active, not recruiting
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
NCT06132958· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

COI Centro Oncologico Internacional S.A.P.I. de C.V. (Site 2902): trial site – Frontlight Research